Nature Communications (Apr 2022)
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
Abstract
A rare sub-population of people living with HIV-1 experience long-lasting viral remission after interrupting antiretroviral therapy and are considered post-treatment controllers. Here the authors characterise the humoral immune response to HIV-1 in a cohort of post-treatment controllers.